drugset / Trial / NCT02469545

Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment

NCT02469545

Phase 2 Completed 60 enrolled Medical University of Bialystok
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to determine the influence of supplementation of probiotic Lactobacillus Plantarum 299V vs. placebo of probiotic during antidepressant monotherapy with SSRI (Selective Serotonin Reuptake Inhibitor) in patients with major depression.

Timeline

Start
2014-06
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus plantarum 299v Other / unclassified 1e+10 cells
Comparator Escitalopram Small molecule 5 mg
Comparator Escitalopram Small molecule 20 mg
Comparator Sertraline Small molecule 50 mg
Comparator Sertraline Small molecule 100 mg